> Akrikhin, OJSC (Moscow)
This information cannot be used for self-treatment!
Be sure to consult with a specialist!
The full name of the company is Akrikhin Chemical and Pharmaceutical Plant. It is a Russian company engaged in the production of various dosage forms: tablets, syrups, ointments, creams and capsules. Most of the manufactured products are focused on socially significant therapeutic areas of medicine. These include endocrinology, cardiology, neurology, phthisiology, gynecology.
In Russia, OJSC Akrikhin was officially registered in 2003, although the history of the production begins in 1936, when the manufacturer produced a batch of the antimalarial drug Akrikhin, which later gave the name of the company.
Currently, the actual owner of JSC Akrikhin is the Hungarian pharmaceutical giant Gedeon Richter, who owns more than 80% of the company's shares. Another co-owner is the Polish pharmaceutical company Polpharma. Foreign investments allowed the chemical-pharmaceutical plant to enter the top ten Russian drug manufacturers. About 40% of all drugs produced are included in the list of vital drugs
Akrikhin produces the following medicines:
- gel Azelik to fight acne;
- creams and ointments for the treatment of atopic dermatitis and complicated dermatoses - Akriderm-Ghenta, Akriderm-GK;
- tablets Acridilol and Acripamide for the treatment of coronary heart disease;
- effervescent tablets for the treatment of hangovers - Alka-Prim;
- drops for children Bobotic from bloating;
- ointment and tablets Acyclovir-Acri for the treatment of herpes infection;
- analgesic drug Bystrumgel;
- drugs for the treatment of varicose veins - Venolife;
- drugs for the treatment of diabetes - Glidiab and Glimecomb;
- dietary supplement Zhuravit;
- anti-tuberculosis drugs Isocomb, Pask-Akri, Pyrazinamide-Akri, Rifapex;
- drug for the treatment of allergic reactions - Clarotadine tablets and syrup;
- antimicrobial agent Clindamycin for the treatment of bacterial vaginosis;
- antidiarrheal drug Loperamide-Acri;
- Mycozoral therapeutic shampoo with antifungal effect;
- eubiotics Normobact, Normobact Junior for the treatment of dysbacteriosis;
- Nozzle- patch for inhalation;
- ophthalmic biological supplement - SuperOptic;
- Trombopol- a means for "thinning" the blood;
- drugs for the treatment of diseases of the musculoskeletal system - Febrofid-gel, Diclofenac;
- antihypertensive pills Enalapril-Acre;
- L-Thyroxine-Acre- a drug for the treatment of thyroid diseases.
The company JOINT STOCK COMPANY "CHEMIKO-PHARMACEUTICAL PLANT "AKRIKHIN" 5031013320 is registered at 142450, MOSCOW REGION, STARAYA KUPAVNA CITY, NOGINSKY DISTRICT, KIROV STREET, 29. The organization was registered on 09.08.2002. The management of the organization is carried out by the PRESIDENT CHETVERIKOV DENIS VALERIEVICH.In accordance with the registration documents, the main activity is the Production of medicines and materials used for medical purposes.For more detailed information, you can go to the company card and check the counterparty for reliability.
Interdistrict Inspectorate of the Federal Tax Service No. 23 for the Moscow Region registered AKRIKHIN JSC on 09.08.2002. The registration procedure in the State Institution - Office of the Pension Fund of the Russian Federation No. 13 Noginsk district of the Moscow region was initiated on 14.08.2006. On the account in the Branch No. 31 of the State Institution - the Moscow Regional Regional Branch of the Social Insurance Fund of the Russian Federation, the company JSC "AKRIKHIN" became 18.10.2008 00:00:00. The last entry in the Unified State Register of Legal Entities that is contained about this company: State registration of changes made to the constituent documents of a legal entity related to changes in the information about the legal entity contained in the Unified State Register of Legal Entities, based on an application.
"AKRIKHIN" today it is one of the leading Russian pharmaceutical companies producing affordable, effective and high-quality medicines.
AKRIKHIN was founded in 1936. The company is among the top 10 largest local pharmaceutical manufacturers in terms of sales and production volume on the Russian pharmaceutical market.
The company's product portfolio includes more than 200 types of medicines (more than 100 brands) of the main pharmaco-therapeutic areas: cardiology, neurology, dermatology, gynecology, pediatrics, ophthalmology, urology. These are preparations both produced by AKRIKHIN and brought to the Russian market in partnership with other companies.
AKRIKHIN releases a wide range of socially significant, contributing to the development of the Russian healthcare system. The company is one of the largest Russian manufacturers of drugs included in the List of Vital and Essential Drugs (VED), as well as drugs for the treatment of tuberculosis and diabetes.
Production complex "AKRIKHINA" is located 20 km from Moscow. The company's production includes workshops for the production of drugs of almost all forms: tablets, capsules, liniments, ointments, creams, syrups, gels, suppositories, etc. The company's annual output is more than 50 million packages. are produced on foreign equipment from high-quality raw materials based on the latest technologies. The modern warehouse complex of AKRIKHIN has more than 8 thousand pallet places that ensure proper storage of medicines.
Since 2007, AKRIKHIN's strategic partner on the Russian pharmaceutical market has been Polpharma. Strategic cooperation between AKRIKHIN and Polpharma includes:
- combined product portfolio,
- transfer of production technologies and cooperation in the field of research and development,
- access to international management standards and technologies, employee training, exchange programs.
In 2011, Polpharma strengthened and expanded the partnership by acquiring a majority stake in AKRIKHIN.
The AKRIKHIN production complex includes:
- 2 production facilities for the production of finished dosage forms:
- solid finished dosage forms,
- soft and liquid finished dosage forms;
- Center for Quality Control;
- R&D laboratory;
- Finished products warehouse;
- Customs warehouse;
- Warehouse of raw materials and materials.
Each stage of the creation of a medicinal product is accompanied by quality control. This is ensured by the company's quality assurance system. AKRIKHIN regularly successfully passes audits of foreign partners and regulatory authorities for compliance of the quality assurance system and quality management system with ISO standards and rules.
In 2010, AKRIKHIN launched an investment program for the period 2010-2016. for the modernization and development of the production complex with a total investment of more than 40 million dollars. As a result of the implementation of the investment program, the company will significantly increase the volume of manufactured products and finally complete the transition of the entire production complex to meet the requirements of international quality standards
How to disable ads on Android: remove pop-up ads
The Russian received a term and a million fine for "piracy Negative consequences of the law
Identification of key factors
The criteria for classifying organizations and individual entrepreneurs as small and medium-sized businesses have changed
See what "Royalty" is in other dictionaries Pitfalls of legislation